Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH
First author of the article - Max Hoebink/LinkedIn
Jun 5, 2026, 09:58

Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions – JTH

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by Max Hoebink, et al, adding:

”Clinical Applicability of Anti-Xa Measurements to Monitor Unfractionated Heparin Activity During Arterial Procedures: A Scoping Review

This scoping review of 55 reports finds that while anti-Xa is a reliable reference test for heparin monitoring during arterial procedures, optimal target levels and their correlation with clinical outcomes remain poorly defined.”

Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review

Authors: Max Hoebink, Tom Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind

Evaluating Anti-Xa Targets and Outcomes in Arterial Interventions - JTH

Stay updated on all scientific advances with Hemostasis Today.

anti-Xa Arno Wiersema Health Hematology Hemostasis Hemostasis News Hemostasis Today Henrike Hamer Heparin JTH Kak Khee Yeung Max Hoebink Medicine Sjoerd Smit thrombosis Tom Steunenberg Vincent Jongkind
NewsFeed